Patent ID: 9572887
Date: 2017-02-21
CPC Classifications: A61K,A61P

Claim:
1. A method of treating chronic lymphocytic leukemia or indolent B cell non-Hodgkin's lymphoma in a subject comprising: a. providing a non-aqueous liquid composition comprising from about 10 mg/mL to about 100 mg/mL of bendamustine or a pharmaceutically acceptable salt thereof, wherein the total impurities are less than about 5% as determined by HPLC at a wavelength of 223 nm after 15 months at a temperature of from about 5° C. to about 25° C.; b. diluting said non-aqueous liquid composition with a parenterally acceptable aqueous diluent; and c. parenterally administering said diluted composition to the subject at a bendamustine dosage ranging from about 25 mg/m